Filling the Gap to Address Vaccine Hesitancy in Europe

Tiago Correia1, Anabela da Conceição Pereira2,3, Henrique Barros4

  • 1Global Health and Tropical Medicine, Associate Laboratory in Translation and Innovation Towards Global Health and World Health Organization (WHO) Collaborating Center for Health Workforce Policies and Planning, Institute of Hygiene and Tropical Medicine, Universidade Nova de Lisboa, Lisboa, Portugal.

Public Health Reviews
|February 10, 2025
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
43.8K
Social Proof00:52

Social Proof

Social proof is a form of persuasion based on comparison and conformity. People compare their behavior and actions to what others are doing and will change to conform to do what their peers do.
27.4K
Cross-reactivity00:42

Cross-reactivity

Overview
30.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
139
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769